Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NMTC Relative to the S&P 500

NMTC Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the NeuroOne Medical Technologies Corporation (NASD:NMTC) seasonal charts above shows that a Buy Date of October 21 and a Sell Date of February 11 has resulted in a geometric average return of 13.65% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 31.09% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

To download NMTC seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NMTC